vimarsana.com

Page 3 - Validation Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

LumiraDx High Sensitivity Point of Care Antigen Test Detects Against Leading Variants of Concern including Alpha, Beta, Gamma, and Delta

LumiraDx High Sensitivity Point of Care Antigen Test Detects Against Leading Variants of Concern including Alpha, Beta, Gamma, and Delta
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Novacyt SA (AIM:NCYT) | RNS | Novacyt S A - Research and Development Update

RNS Number: 1141 Q Novacyt S.A. 24 February 2021 Novacyt S.A.. Paris, France and Camberley, UK- 24 February 2021- Novacyt, an international specialist.

Investegate |Novacyt S A Announcements | Novacyt S A : Correction: Research and Development Update

    This is a correction to the Research and Development Update announcement published at 7:00am on 24 February 2021 (RNS number 1141Q) which has been amended with the following underlined additions to make it consistent with the French announcement released on Euronext at 8:00am CET on 24 February 2021.   Under the subtitle Launch of CE Mark COVID-HT Direct · Novacyt announces the launch of its next generation high-throughput PCR test for COVID-19 (COVID-HT Direct), which has been CE Mark approved using independent validated data. · The new COVID-HT Direct uses pharyngeal swabs collected in viral transport media (without guanidine) and saline   Under the subtitle Successful completion and publication of TVG validation of PROmate™

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.